I’ve been thinking about Byju’s quite a bit lately. It wasn’t too long ago when I was having a conversation with a fellow investor about the meteoric rise of Byju’s, India’s education technology darling. Back then, it seemed like every other day, they were either acquiring another company or raising a fresh round of funding. Yet here we are, watching its collapse unfold, and it’s hard not to feel a sense of déjà vu. As an angel investor, I’ve seen the cycle of exuberance and implosion play out time and again. But as an advocate for education reform, the fall of Byju’s holds a particular poignancy.
In the early days, Byju’s was heralded as a game-changer for Indian education—a phrase I normally detest, but it seemed fitting at the time. The idea of leveraging technology to bridge educational gaps was immensely appealing. As someone who invests in startups, I understand the allure of scale and speed. However, as a doctor, I also understand the importance of steady, measured growth—an approach that, unfortunately, Byju’s seemed to overlook.
Why did Byju’s collapse? In a nutshell, Byju’s expanded too quickly without ensuring that its core product was robust enough to support such growth. Imagine a patient undergoing rapid weight gain without strengthening their bones to support it. It’s only a matter of time before fractures occur. Byju’s acquisitions, like the purchase of Aakash Educational Services and WhiteHat Jr, seemed strategic on paper. But in reality, these moves were akin to grafting limbs onto a body not yet ready to support them.
Rapid expansion often blinds companies to operational inefficiencies. For Byju’s, this manifested in its customer acquisition strategy, which was aggressive to the point of being unsustainable. I’ve had parents come to me, concerned about the relentless marketing tactics they were subjected to—calls and messages that bordered on harassment. If there’s one thing I’ve learned from both medicine and investing, it’s that pressure seldom yields positive long-term results. In Byju’s case, it led to customer dissatisfaction and attrition, the cracks in its once formidable facade.
Financial mismanagement also played a significant role. Byju’s, at one point, was valued at over $22 billion, a figure that created unrealistic expectations both internally and externally. When numbers become the primary focus, the mission often takes a backseat. In Byju’s quest to justify its valuation, it lost sight of the very essence of education: genuine learning and understanding. This is a lesson I’ve emphasized time and again to the startups I mentor—value lies not in numbers but in impact.
Let’s not forget the regulatory hurdles. Byju’s found itself at odds with several policies aimed at protecting consumer interests. In India, the education sector is heavily regulated, and for good reason. Education is not just another commodity; it’s a cornerstone of society. By failing to adhere to regulatory standards, Byju’s not only tarnished its reputation but also highlighted a systemic issue within the ed-tech space: the reckless pursuit of growth at the expense of ethical considerations.
Now, let’s address the elephant in the room: did Byju’s collapse because it was an online platform? While the online model has its challenges, it’s not the root cause. The pandemic, after all, accelerated the shift to digital learning, and many platforms thrived. The issue was not with the medium but with the message—or rather, the lack thereof. Byju’s failed to maintain the trust of its primary stakeholders: students and parents. Trust, once broken, is incredibly hard to rebuild, a reality I’ve often observed in both patient-doctor and investor-entrepreneur relationships.
So, what does this mean for parents? It’s a reminder to be vigilant. As I’ve mentioned in my post, “The Questions Skeptical Parents Are Right to Ask”, parents must scrutinize educational offerings critically. Always ask, “Is this truly beneficial for my child?” The collapse of Byju’s underscores the importance of not getting swept up in the hype. Education is a marathon, not a sprint. It demands patience, critical thinking, and, most importantly, a focus on fundamentals.
In reflecting on Byju’s rise and fall, I’m reminded of the importance of balance—a lesson drawn from both investing and medicine. Just as a treatment plan must align with a patient’s unique needs, an educational strategy should prioritize long-term learning over short-term gains. To every parent reading this, remember: your role is not just to provide resources but also to guide your child in discerning what is truly valuable. Let Byju’s serve as a cautionary tale, a reminder that in education, as in life, authenticity and integrity must never be compromised.
As for Byju’s, I genuinely hope they learn from this experience. Failure, when met with reflection and humility, can be transformative. And while the company may have faltered, the broader goal of revolutionizing education remains. We owe it to the next generation to strive for an educational landscape that empowers true learning. As an investor, a doctor, and a concerned advocate, I remain hopeful for what the future holds.